183 related articles for article (PubMed ID: 2594368)
1. High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma.
Bongarzone I; Pierotti MA; Monzini N; Mondellini P; Manenti G; Donghi R; Pilotti S; Grieco M; Santoro M; Fusco A
Oncogene; 1989 Dec; 4(12):1457-62. PubMed ID: 2594368
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident.
Fugazzola L; Pilotti S; Pinchera A; Vorontsova TV; Mondellini P; Bongarzone I; Greco A; Astakhova L; Butti MG; Demidchik EP
Cancer Res; 1995 Dec; 55(23):5617-20. PubMed ID: 7585643
[TBL] [Abstract][Full Text] [Related]
3. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.
Greco A; Pierotti MA; Bongarzone I; Pagliardini S; Lanzi C; Della Porta G
Oncogene; 1992 Feb; 7(2):237-42. PubMed ID: 1532241
[TBL] [Abstract][Full Text] [Related]
4. Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas.
Castellone MD; Guarino V; De Falco V; Carlomagno F; Basolo F; Faviana P; Kruhoffer M; Orntoft T; Russell JP; Rothstein JL; Fusco A; Santoro M; Melillo RM
Oncogene; 2004 Aug; 23(35):5958-67. PubMed ID: 15184868
[TBL] [Abstract][Full Text] [Related]
5. Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation.
Bounacer A; Schlumberger M; Wicker R; Du-Villard JA; Caillou B; Sarasin A; Suárez HG
Br J Cancer; 2000 Jan; 82(2):308-14. PubMed ID: 10646882
[TBL] [Abstract][Full Text] [Related]
6. The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line.
Santoro M; Melillo RM; Grieco M; Berlingieri MT; Vecchio G; Fusco A
Cell Growth Differ; 1993 Feb; 4(2):77-84. PubMed ID: 8494786
[TBL] [Abstract][Full Text] [Related]
7. Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens.
Notario V; Castro R; Flessate DM; Doniger J; DiPaolo JA
Oncogene; 1990 Sep; 5(9):1425-30. PubMed ID: 2216466
[TBL] [Abstract][Full Text] [Related]
8. Gene rearrangements in radiation-induced thyroid carcinogenesis.
Rabes HM
Med Pediatr Oncol; 2001 May; 36(5):574-82. PubMed ID: 11340615
[TBL] [Abstract][Full Text] [Related]
9. [Thyroid carcinoma].
Namba H; Izumi M
Gan To Kagaku Ryoho; 1991 Jan; 18(1):22-9. PubMed ID: 1987898
[TBL] [Abstract][Full Text] [Related]
10. Identification and expression of human c-Ha-ras and c-sis sequences in NIH3T3 transformants.
Weismanová E; Sabová L
Neoplasma; 1990; 37(6):675-85. PubMed ID: 2274086
[TBL] [Abstract][Full Text] [Related]
11. Rearrangements of NTRK1 oncogene in papillary thyroid carcinoma.
Brzeziańska E; Pastuszak-Lewandoska D; Lewiński A
Neuro Endocrinol Lett; 2007 Jun; 28(3):221-9. PubMed ID: 17627253
[TBL] [Abstract][Full Text] [Related]
12. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.
Russell JP; Powell DJ; Cunnane M; Greco A; Portella G; Santoro M; Fusco A; Rothstein JL
Oncogene; 2000 Nov; 19(50):5729-35. PubMed ID: 11126359
[TBL] [Abstract][Full Text] [Related]
13. Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells.
Castellone MD; Celetti A; Guarino V; Cirafici AM; Basolo F; Giannini R; Medico E; Kruhoffer M; Orntoft TF; Curcio F; Fusco A; Melillo RM; Santoro M
Oncogene; 2004 Mar; 23(12):2188-96. PubMed ID: 14981541
[TBL] [Abstract][Full Text] [Related]
14. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.
Grieco M; Santoro M; Berlingieri MT; Melillo RM; Donghi R; Bongarzone I; Pierotti MA; Della Porta G; Fusco A; Vecchio G
Cell; 1990 Feb; 60(4):557-63. PubMed ID: 2406025
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
Albor A; Thraves PJ; Dritschilo A; Notario V
Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
[TBL] [Abstract][Full Text] [Related]
16. Ret/PTC3 is the most frequent form of gene rearrangement in papillary thyroid carcinomas in Japan.
Kitamura Y; Minobe K; Nakata T; Shimizu K; Tanaka S; Fujimori M; Yokoyama S; Ito K; Onda M; Emi M
J Hum Genet; 1999; 44(2):96-102. PubMed ID: 10083732
[TBL] [Abstract][Full Text] [Related]
17. Novel mutations of the MET proto-oncogene in papillary renal carcinomas.
Schmidt L; Junker K; Nakaigawa N; Kinjerski T; Weirich G; Miller M; Lubensky I; Neumann HP; Brauch H; Decker J; Vocke C; Brown JA; Jenkins R; Richard S; Bergerheim U; Gerrard B; Dean M; Linehan WM; Zbar B
Oncogene; 1999 Apr; 18(14):2343-50. PubMed ID: 10327054
[TBL] [Abstract][Full Text] [Related]
18. Rearrangements of NTRK1 gene in papillary thyroid carcinoma.
Greco A; Miranda C; Pierotti MA
Mol Cell Endocrinol; 2010 May; 321(1):44-9. PubMed ID: 19883730
[TBL] [Abstract][Full Text] [Related]
19. Oncogenes and growth factors in thyroid carcinogenesis.
Frauman AG; Moses AC
Endocrinol Metab Clin North Am; 1990 Sep; 19(3):479-93. PubMed ID: 2175702
[TBL] [Abstract][Full Text] [Related]
20. Tumorigenicity assay of the human mammary carcinoma cell line MCF-7.
Marics I; Adelaide J; Rosnet O; Planche J; Pirisi V; Birnbaum D
Anticancer Res; 1989; 9(6):1627-31. PubMed ID: 2560622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
